PHAXIAM Therapeutics
A biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.
Launch date
Employees
Market cap
CAD24.7m
Enterprise valuation
CAD35m (Public information from Sep 2024)
Share price
$0.5431 ERYP
Company register number 479560013
Lyon Auvergne-Rhône-Alpes (HQ)
Authorizing premium user...